Uzbekistan. Import of pharmaceutical products
In 2010 the imports of pharmaceutical products of the Uzbek companies totalled USD 373.7 million, which was slightly lower than previous Year 2009 (USD 411.6 million). Lower imports are explained by implementation of the number of projects for local production of components to produce finished products.
Nearly 83% of pharmaceutical imports worth USD 309.8 million were designed for retail sales. Finished medical drugs worth USD 204.6 million accounted for more than half – 54.7%.
Medical drugs containing antibiotics worth USD 37.7 million, alkaloids – USD 27.3 million, vitamins worth USD 27.6 million, vaccines worth USD 17.2 million, and other preparations are also imported. Imported drugs currently supply up to 67% up to 95% of the markets of miscellaneous medical drugs from Uzbekistan. Uzbekistan imports drugs mostly from Russia, Germany, Ukraine, India, China, and Hungary. Imports of medical drugs will be growing annually by 21-22% in the next 4-5 years.
Most domestically manufactured medical drugs are generics, produced mostly from imported substances.
Original domestic drugs account for 1.9% of domestic production.
More than 86% of domestic medical drugs are manufactured fully (14%) or mostly (72%) from imported substances, which currently makes domestic production of medications utterly dependant on imports, their quality, and prices. Development of domestic pharmaceutical sector will facilitate not only market saturation by domestic products but also presents the prospects of technological development and increased use of domestic inputs.
Figure 1. Geographic distribution of pharmaceutical products import in Uzbekistan during 2009-2010
Preventive health actions will have an impact on trends and composition of demand in the pharmaceutical market. Inter alia, development of early diagnosis and diagnostics activities in general will increase demand for substances needed for laboratory tests and so on. With emergence of healthy lifestyle, consumption of drugs, which promote disease prevention, will be expanded.
Nearly 83% of pharmaceutical imports worth USD 309.8 million were designed for retail sales. Finished medical drugs worth USD 204.6 million accounted for more than half – 54.7%.
Medical drugs containing antibiotics worth USD 37.7 million, alkaloids – USD 27.3 million, vitamins worth USD 27.6 million, vaccines worth USD 17.2 million, and other preparations are also imported. Imported drugs currently supply up to 67% up to 95% of the markets of miscellaneous medical drugs from Uzbekistan. Uzbekistan imports drugs mostly from Russia, Germany, Ukraine, India, China, and Hungary. Imports of medical drugs will be growing annually by 21-22% in the next 4-5 years.
Most domestically manufactured medical drugs are generics, produced mostly from imported substances.
Original domestic drugs account for 1.9% of domestic production.
More than 86% of domestic medical drugs are manufactured fully (14%) or mostly (72%) from imported substances, which currently makes domestic production of medications utterly dependant on imports, their quality, and prices. Development of domestic pharmaceutical sector will facilitate not only market saturation by domestic products but also presents the prospects of technological development and increased use of domestic inputs.
Figure 1. Geographic distribution of pharmaceutical products import in Uzbekistan during 2009-2010
Source: UNDP
Leave a Comment